The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan.

Yudai KanekoAkira SugiyamaToshiya TanakaKazushige FukuiAkashi TaguchiKenji TatsunoAya NakayamaKazumasa KogaYoshiro KishiWang DamingChungen QianFuzhen XiaFan HeLiang ZhengYi YuYouichiro WadaYoshiaki WadaTatsuhiko KodamaTakeshi Kawamura

Published in: Health science reports (2022)

Our findings indicate COVID-19 patients should be examined for IgG, IgA, and IgM against SARS-CoV-2 structural proteins and NAbs against SARS-CoV-2 to analyze the diversity of patients' immune mechanisms.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
transcription factor